Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...

Handelsbanken Fonder AB trimmed its holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) by 14.8% during the fourth quarter, according to the company in its most recent filing with the ...

Accelerated execution of Phase 2 APEX clinical trial for APG777, with Part A over-enrolled and Part B initiated ahead of schedule; topline Part A ...

The Phase I trial will recruit approximately 98 healthy volunteers and adults living with atopic dermatitis at a single site ...

Warner Bros. Discovery's potential extends beyond its DTC business, with multiple avenues for future growth and profitability ...

A seemingly minor update to Dota 2 is enough to spark speculation that Half-Life 3 is nearing completion. Rumours of Valve ...

BeiGene, Ltd. , a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced financial results and corporate updates from the fourth quarter and full year 2024.

Unexplained peak in the abundance of beryllium-10 in ferromanganese ocean crusts could become an independent time marker for geological dating ...

Topline data from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN expected by Q4 2025Anticipate completing enrollment in ...

CBSE Class 12 Chemistry Board Exam 2025 on7. Check key topics list, preparation tips, time management tricks shared by PGT ...

Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

Microplastics and pesticides both pose a threat to the environment. Together, the two further threaten agriculture and food ...